In 2017, 22nd Century Group revealed that it would be focusing on developing more reduced risk products due to the FDA’s focus on lowering nicotine in tobacco products [read more here].
For all the latest news from 22nd Century Group, Inc., visit xxiicentury.com.
 with the U.S. Food and Drug Administration for its VLN premium cigarettes.){kind=link}